ctDNA Recordings
Educational recordings about circulating tumor DNA (ctDNA) testing and liquid biopsies for Leiomyosarcoma patients and healthcare providers.
Current Status of Circulating Tumor DNA for Sarcomas — Discussion by a Panel of Experts
Expert Panel — Five Institutions
Dana-Farber, Stanford, Princess Margaret, James Cancer Center & McGill University
November 2025
Five leading physician-scientists discuss the current landscape of ctDNA and liquid biopsy research in sarcoma and leiomyosarcoma. The panel covers the unique challenges of detecting ctDNA in soft tissue sarcomas, emerging evidence that ctDNA levels can predict recurrence before imaging, and novel assay approaches — including tracking structural variants — that may enable earlier intervention for high-risk patients.
More ctDNA & Liquid Biopsy Recordings
Circulating Tumor DNA Status and Future Directions for Sarcoma
Expert Panel
Multiple Institutions
2023
Panel discussion with experts including Dr. Nam Quoc Bui, Dr. Brian Compton, Dr. Elizabeth Davis, Dr. Erlinda Maria Gordon, Dr. Matthew Hemming, Dr. Elise Nasif, Dr. Joanna Pryzbyl, Dr. David Schulman and Dr. Jonathan Trent.
The Role of Circulating Tumor DNA (ctDNA) in Leiomyosarcoma
Dr. Kristin Ganjoo & Dr. Katie Baker
Stanford University & Natera/Signatera
March 27, 2022
Dr. Ganjoo and Dr. Baker discuss how circulating tumor DNA testing can be used in the management of Leiomyosarcoma.
Circulating DNA in Uterine Leiomyosarcoma and Benign Uterine Leiomyosarcomas
Dr. Joanna Przybyl
The Research Institute of Montreal at McGill University
February 24, 2022
Dr. Przybyl presents research on using circulating DNA to differentiate between uterine LMS and benign conditions.
The Role of Nomograms in the Treatment of LMS and the Potential Future Impact of Circulating Tumor DNA
Dr. Kenneth Cardona
Emory University Winship Cancer Institute, Atlanta, GA
February 17, 2022
Dr. Cardona discusses the role of nomograms and the potential impact of circulating tumor DNA on LMS treatment.
Current LMS/Sarcoma Research Projects and Perspectives on ctDNA
Dr. Dale Shepherd
Cleveland Clinic, Cleveland, OH
February 2, 2022
Dr. Shepherd discusses current LMS/sarcoma research and the status of ctDNA applications for sarcoma.
ct-DNA Proof of Concept Research for Sarcoma
Dr. Brian Crompton
Dana-Farber Cancer Institute, Boston, MA
November 30, 2021
Dr. Crompton presents proof-of-concept research on circulating tumor DNA for sarcoma.
Understanding ctDNA
Learn how ctDNA testing works, why it matters, and how it may impact monitoring and treatment planning for sarcoma patients.
Patient Resources
Explore NLMSF resources to navigate testing, treatment decisions, and clinical trial options.
Related Clinical Trials
Looking for active or upcoming trials? Visit our clinical trials resources to learn about eligibility and next steps.